Abstract
To date, there are still many un resolved questions in the management of patients with coronary artery disease
who have shown the emergency treatment non-cardiac pathology. In this connection, great interest is
the evaluation of the results of staged treatment of patients with ischemic heart disease and cancer-when the
first stage was performed coronary stenting, and the second - the treatment of cancer pathology.
Material and methods. This paper presents the results of a two-stage treatment of 35 patients with coronary
heart disease (all of them performed percutaneous coronary intervention) and cancer (16 patients of the second
stage was carried out surgical treatment, 16 - chemotherapy or radiotherapy and 3 - combined treatment).
Results. There was not a single case of intra-operative and hospital mortality during the 2 stage treatment of
coronary heart disease and cancer pathology. Have been reported as cases of acute violation of the coronary
circulation during the second stage - the treatment of cancer pathology. In 3 (8.6%) patients had marked the
return of angina clinic within one year after myocardial revascularization (coronary angiography revealed
when restenosis in a previously implanted stent), which has required re-stenting. Mortality within one year
after myocardial revascularization was 14.3%: 5 patients died within 2-3 months after PCI in connection
with the progression of cancer pathology.
Conclusion. The results indicate high perfomance of percutaneous coronary intervention performed the first
stage. Hospital mortality was not registered. Deaths within a year after PCI were due to the progression of
cancer.
References
- Chan A.O., Jim M.H., Lam K.F., Morris J.S.,
SiuD.C., Tong T. et al. Prevalence of colorectal
neoplasm among patients with newly diagnosed
coronary artery disease. JAMA. 2007; 298(12):
1412-19.
- NeugutA.I., Rosenberg D.J., Ahsan H., Jacobson J.S.,
Wahid N., Hagan M.et al. Association between coronary
heart disease and cancers of the breast, prostate,
and colon. Cancer Epidemiol. Biomarkers Prev. 1998;
7(10): 869-73.
- Шестопалова И.М. Стратегия диагностики
и лечения ишемической болезни сердца в тора-
ко-абдоминальной онкохирургии. Автореф.
дис. ... д-ра мед. наук. М.; 2010.
- Hawn M.T., Graham L.A., Richman J.S.,
Itani K.M., Henderson W.G., Maddox T.M. Risk of
major adverse cardiac events following noncardiac
surgery in patients with coronary stents. JAMA.
2013; 310(14): 1462-72.
- Kaluza G.L., Joseph J., Lee J.R., Raizner M.E.,
Raizner A.E. Catastrophic outcomes of noncardiac
surgery soon after coronary stenting. J. Am. Coll.
Cardiol. 2000; 35(5): 1288-94.
- Kristensen S.D., Knuuti J., Saraste A., Anker S.,
Botker H.E., De Hert S. et al. 2014 ESC/ESA
Guidelines on non-cardiac surgery: cardiovascular
assessment and management: The Joint Task Force
on non-cardiac surgery: cardiovascular assessment
and management of the European Society of
Cardiology (ESC) and the European Society of
Anaesthesiology (ESA). Eur. Heart J. 2014; 14;
35(35): 2383-431.
- Savonitto S., D'Urbano M., Caracciolo M., Barlocco
F., Mariani G., Nichelatti M. et al. Urgent surgery
in patients with a recently implanted coronary drugeluting
stent: a phase II study of "bridging"
antiplatelet therapy with tirofiban during temporary
with drawal of clopidogrel. Br. J. Anaesth. 2010;
104(3): 285-91.
- Guo Q., Zhang B., Dong X., Xie Q., Huang H. et al.
Elevated levels of plasma fibrinogen in patients with
pancreatic cancer: possible role of adistant metastas
is predictor. Pancreas. 2009; 38(3): e75-9.
- Lee S.E., Lee J.H., Ryu K.W., Nam B.H., Cho S.J.,
Lee J.Y. et al. Preoperative plasma fibrinogen level is
a useful predictor of adjacent organ involvement in
patients with advanced gastric cancer. J. Gastric.
Cancer. 2012; 12(2): 81-7.
- Барбухатти К.О., Позднякова О., Мироненко С.П.
Россейкин Е.В., Поляков И.С., Порханов В.А. Современные
возможности хирургического лечения
больных ишемической болезнью сердца с
объемными образованиями легких. Патология
кровообращения и кардиохирургия. 2005; 2: 78-82.
- Азовцев Р.А., Морозов В.П., Пудяков П.С. Тактика
лечения больного с сочетанием рака пищевода
и атеросклеротического поражения коронарных
и мозговых артерий. Вестник хирургии.
2010; 1: 124-6.
- Нохрин А.В., Хубулава Г.Г., Касарева Н.А., Дру-
кин Э.Я., Юрченко Д.Л., Гунят Р.Я. и др. Хирургическое
лечение больного раком легкого с тяжелой
коронарной недостаточностью. Вестник
хирургии. 2010; 3: 126.
- Давыдов М.И., Акчурин Р.С., Герасимов С.С., Дзе-
мешкевич С.Л., Бранд Я.Б., Долгов И.М. и др. Сочетанное
хирургическое лечение онкологических
больных с конкурирующими сердечно-сосудистыми
заболеваниями при опухолевых
поражениях легких и средостения. Хирургия.
2010; 8: 4-11.
- Velders M.A., Boden H., Hofma S.H., Osanto S.,
van der Hoeven B.L., Heestermans A.A. еt al.
Outcome after ST elevation myocardial infarction
in patients with cancer treated with primary percutaneous
coronary intervention. Am. J. Cardiol.
2013; 112(12): 1867-72.
- Voltolini L., Rapicetta C., Luzzi L., Paladini P.,
Ghiribelli C., Scolletta S. et al. Lung resection for
non-small cell lung cancer after prophylactic coronary
angioplasty and stenting: short- and long-term
results. Minerva Chir. 2012; 67(1): 77-85.
